Gut health indicators, either through stool testing or careful observation of digestive patterns
Longer-Term Progress Participants who remained in treatment continued to be monitored for sustained weight reduction, appetite control, tolerability, and any new or persistent safety concerns
The compound reaches peak blood levels within 1-3 hours of sublingual administration, which means the strongest appetite control kicks in right around lunchtime, precisely when food decisions tend to get difficult for most people managing their diet on GLP-1 medications
Applying GHK-Cu to large areas of broken or heavily compromised skin, or using it in injectable or oral forms, bypasses the barrier that keeps topical exposure low
In as-treated analyses median follow-up was 1 year [0-2] for both new GLP-1 RA users and new SGLT-2 inhibitor users